Compare Bundamedik Tbk (BMHS) vs Suparma Tbk. (SPMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Suparma Tbk. — how do they compare? Bundamedik Tbk trades at Rp189 (market cap 1.62T, 13.7K 24h volume), while Suparma Tbk. trades at Rp165 (market cap 874.19B, 475.9K 24h volume). The key difference: Bundamedik Tbk is the larger of the two by market cap, and Suparma Tbk. is more actively traded (475.9K versus 13.7K). Which is the better fit depends on your goals.
| BMHS | SPMA | |
|---|---|---|
Market Cap | 1.62T | 874.19B |
Volume | 13.7K | 475.9K |
Lot | 137 | 4.76K |
Turnover | 2.6M | 80.62M |
Average Price | 189.85 | 169.41 |
Value | 2.6M | 80.62M |
Indicative Equilibrium Price | 190 | — |
Indicative Equilibrium Volume | 52 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Suparma Tbk.
PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →
